Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL267255 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL12335953 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL4890632 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL7596228 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL10496307 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL10496303 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL1921557 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| Heptanal Oxime SCHEMBL15257172 | 1.00 | — | — | |
| Heptanal Oxime SCHEMBL265491 | 1.00 | — | — | |
| SCHEMBL265367 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110964218-B | Water-resistant PVA film and preparation method thereof | 江门市新构思环保科技有限公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-3365897-B1 | USE OF ALDOXIMES COMPRISING AT LEAST 5 FIVE CARBON ATOMS AS ANTI-NITRIC AGENT IN REDUCTIVE PLUTONIUM BACK-EXTRACTION-OPERATIONS | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2019-11-06 | — | — | EP | disclosed |
| EP-3365897-A1 | USE OF ALDOXIMES COMPRISING AT LEAST FIVE CARBON ATOMS AS ANTI-NITROUS AGENTS IN OPERATIONS FOR THE REDUCTIVE BACK-EXTRACTION OF PLUTONIUM | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2018-08-29 | — | — | EP | disclosed |
| WO-2017067933-A1 | USE OF ALDOXIMES COMPRISING AT LEAST FIVE CARBON ATOMS AS ANTI-NITROUS AGENTS IN OPERATIONS FOR THE REDUCTIVE BACK-EXTRACTION OF PLUTONIUM | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-04-27 | — | — | WO | disclosed |
| EP-1655070-B1 | OXIDATION CATALYST | ASAHI KASEI CHEMICALS CORP (JP) | 2015-07-15 | — | — | EP | disclosed |
| WO-2015043473-A1 | GLUCOPYRANOSYL DERIVATIVES AND THEIR USES IN MEDICINE | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2015-04-02 | — | — | WO | disclosed |
| CN-103172482-B | Method for preparing first-grade amide from aldoxime or formaldehyde and hydroxylamine | UNIV WENZHOU | 2015-02-18 | — | — | CN | disclosed |
| CN-103172482-A | Method for preparing first-grade amide from aldoxime or formaldehyde and hydroxylamine | UNIV WENZHOU | 2013-06-26 | — | — | CN | disclosed |
| US-8133834-B2 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| CN-1835800-B | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2010-04-28 | — | — | CN | disclosed |
| US-20100069670-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20060229471-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2006-10-12 | — | — | US | disclosed |
| CN-1835800-A | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2006-09-20 | — | — | CN | disclosed |
| EP-1655070-A1 | OXIDATION CATALYST | Asahi Kasei Chemicals Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| US-7025899-B2 | Concentrated solutions of oxime metal extractants and method of formulating extractant compositions therefrom | COGNIS CORPORATION (US) | 2006-04-11 | — | — | US | disclosed |
| EP-0080700-B2 | A process for producing nitrile compounds | SUMITOMO CHEMICAL CO (JP) | 1994-08-17 | — | — | EP | disclosed |
| EP-0080700-B1 | A PROCESS FOR PRODUCING NITRILE COMPOUNDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-04-23 | — | — | EP | disclosed |
| US-4456562-A | AZEOTROPIC DISTILLATION OF WATER FROM REACTION PRODUCT OF ANALDEHYDE AND HYDROXYLAMINE OR ALDOXIME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-06-26 | — | — | US | disclosed |
| EP-0080700-A1 | A process for producing nitrile compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069670-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | TSHR 4696/4885THRB 4740/4885EP300 1250/4885 |
| US-20060229471-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | TSHR 4696/4885THRB 4740/4885EP300 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.